21 May 2013
Keywords: correction, merck, co, januvia, april, issue, pharma
Article | 07 May 2007
In the April 30 issue of Pharma Marketletter we reported that Merck & Co's antidiabetic agent Januvia (sitagliptin) is currently under US
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 May 2007
20 May 2013
© 2013 thepharmaletter.com